NEO Stock: Price, Earnings History and SEC Filings
NeoGenomics, Inc. (NEO) last traded at $17.38, down 3.07% on the latest session and down 5.3% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $0.01 against an analyst estimate of $-0.01, a beat of 200.0%.
$17.38 -3.07%
1 month-5.34%
52-week high$20.15
52-week low$7.07
Volume1.46M
ExchangeNasdaqCM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
NEO earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $0.01 | $-0.01 | +200.00% |
| Jun 2026 | Jul 28, 2026 | $-0.01 | $-0.06 | +83.33% |
| Mar 2026 | Apr 28, 2026 | $-0.06 | $-0.08 | +25.00% |
| Dec 2025 | Feb 17, 2026 | $0.00 | $-0.05 | +100.00% |
NEO beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for NEO
SEC filing data is not available right now. You can search for NEO on SEC EDGAR.
NEO news
- 5 revealing analyst questions from NeoGenomics’s Q3 earnings callOct 31, 2026 · finance.yahoo.com
- NeoGenomics (NEO) Beat Q3 Expectations, Is The Stock Still Cheap?Oct 29, 2026 · finance.yahoo.com
- What NeoGenomics (NEO) Said on Its Q3 Earnings CallOct 29, 2026 · marketbeat.com
- NeoGenomics (NEO) Q3 2026 Earnings Call TranscriptOct 29, 2026 · fool.com
- NeoGenomics (NEO) Q3 Earnings and Revenues Beat EstimatesOct 28, 2026 · finance.yahoo.com
- NeoGenomics: Q3 Earnings SnapshotOct 28, 2026 · finance.yahoo.com
- NeoGenomics’s (NASDAQ:NEO) Q3 2026 sales beat estimatesOct 28, 2026 · finance.yahoo.com
- NeoGenomics Reports Third Quarter 2026 ResultsOct 28, 2026 · finance.yahoo.com
About NeoGenomics, Inc.
NeoGenomics, Inc. (NEO) is a US-listed public company on Nasdaq.